Clinical Trial Update: Efficacy and Safety Study of Argatroban to Treat Heparin-Induced Thrombocytopenia [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating the efficacy and safety of Argatroban for treating heparin-induced thrombocytopenia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heparin-induced Thrombocytopenia

Drugs mentioned

• Argatroban (argatroban)

Snippet

Sponsor: Ministry of Health, Labour and Welfare, Japan | Conditions: Heparin-Induced Thrombocytopenia | Phase 3 | Status: COMPLETED